Spinal cord injury is one of the most dangerous complications of scoliosis orthopedic
surgery, and the Stagnara awakening test has been used in orthopedic spine surgery and is
considered the "gold standard" for detecting spinal cord injury. During the awakening test,
the patient is awakened from anesthesia and, in conjunction with a neurological assessment,
moves his or her fingers and toes to determine the integrity of spinal cord motor function in
order to avoid spinal cord injury. During this procedure, the patient still requires a degree
of sedation and analgesia to tolerate tracheal intubation and surgical pain. Remazolam
benzoate for injection is a new class of benzodiazepines that are ultra-short-acting
sedative/anesthetic drugs. It has the advantages of rapid onset, rapid elimination, and no
drug accumulation by continuous infusion, and has the advantage of being applied to wake up
during spinal orthopedic surgery, but its effectiveness and safety are still unclear. This
study aims to elucidate the safety and efficacy of rimazolam benzoate for injection for
arousal in spinal orthopedic surgery through a single-center, randomized, single-blind,
positive drug-controlled trial, with the aim of providing a basis for the development of a
safe and effective anesthetic protocol for such surgery.